文献速递主动脉疾病

医师改良开窗腔内修复对比开放转换治疗EVAR后Ia型内漏

Physician-Modified Fenestrated Endovascular Aortic Aneurysm Repair after Failed EVAR with Type I Endoleak Offers Favorable Results Compared to Open Conversion.
PubMed 文献 · Ann Vasc Surg · 2026-08-22

单中心回顾性研究比较101例EVAR后Ia型内漏患者,41例开放转换(EVAR-c)与60例医师改良开窗/分支腔内修复(PM-F/BEVAR)。PM-F/BEVAR组30天死亡率(0% vs 15%,P=0.004)和术后并发症(23% vs 75%,P<0.001)显著更低,但4年总生存无差异(49% vs 64%,P=0.71)。

要点

  • PM-F/BEVAR可显著降低EVAR后Ia型内漏患者的30天死亡率和并发症。
  • 两组4年总生存率无显著差异,围术期优势未转化为远期生存获益。
  • 排除紧急/急诊病例后,PM-F/BEVAR的围术期优势持续存在。

核心结论

  • PM-F/BEVAR是治疗EVAR后Ia型内漏安全有效的腔内挽救方案,30天结局显著优于开放转换。
  • PM-F/BEVAR的围术期生存优势随时间推移消失,4年总生存与开放转换无差异。

研究设计与样本

  • 按治疗策略分为开放转换组(EVAR-c,n=41)和医师改良开窗/分支腔内修复组(PM-F/BEVAR,n=60)。
  • 采用单因素分析比较两组人口学、手术细节和术后并发症,Kaplan-Meier法比较4年总生存。

主要发现

  • PM-F/BEVAR组30天死亡率显著低于EVAR-c组(0% vs 15%,P=0.004)。
  • PM-F/BEVAR组术后并发症显著少于EVAR-c组(23% vs 75%,P<0.001)。
  • 两组4年总生存率无显著差异(PM-F/BEVAR 49% vs EVAR-c 64%,P=0.71)。
  • 排除紧急/急诊病例后,PM-F/BEVAR的围术期结局优势持续存在。

临床怎么用

  • 对于EVAR后Ia型内漏、解剖条件允许的患者,可优先考虑PM-F/BEVAR以降低围术期风险。
  • 需向患者说明PM-F/BEVAR的围术期优势可能不转化为远期生存获益。

局限性

  • 单中心回顾性研究,样本量有限(共101例),可能存在选择偏倚。
  • 原文未报告急诊/择期比例及具体并发症类型等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: EVAR failure due to type Ia endoleak is prevalent. Conversion to open repair (EVAR-c) is associated with technical and physiologic challenges. Endovascular salvage by obtaining a more proximal seal zone with a physician-modified fenestrated/branched endovascular repair (F/BEVAR) is an alternative treatment option. There is limited data directly comparing outcomes of EVAR-c and PM-F/BEVAR. The purpose of this study was to compare outcomes of EVAR-c and PM-F/BEVAR in patients with prior EVAR with type Ia endoleak and to assess changes in our clinical management of these patients over time. METHODS: A prospective database of patients treated at a single center with EVAR failure due to type Ia endoleak between January 2015 and November 2025 was retrospectively reviewed. The cohort was stratified by treatment strategy, either EVAR-c or PM-F/BEVAR. Demographics, operative details, and postoperative complications were compared between the groups using univariate analysis. Four-year overall survival was compared using the Kaplan-Meier method. RESULTS: Of the 101 patients treated for failed EVAR with type Ia endoleak, 41 underwent EVAR-c and 60 underwent PM-F/BEVAR. While both groups had similar preoperative characteristics, PM-F/BEVAR had significantly decreased 30-day mortality (n = 6 [15%] vs. n = 0 [0%]; P = 0.004) and postoperative complications (n = 14 [23%] vs. n = 30 [75%]; P < 0.001). There was no difference in 4-year overall survival (EVAR-c = 64% vs. PM-F/BEVAR = 49%; P = 0.71). The improved perioperative outcomes with PM-F/BEVAR was persistent when excluding urgent/emergent cases from analysis. CONCLUSION: Endovascular salvage of failed prior EVAR due to type Ia endoleak with PM-F/BEVAR is safe and effective with significantly better 30-day outcomes compared to EVAR-c, but this survival advantage is lost over time.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Natarajan JP, Nguyen T, Patel S, et al. Physician-Modified Fenestrated Endovascular Aortic Aneurysm Repair after Failed EVAR with Type I Endoleak Offers Favorable Results Compared to Open Conversion. Ann Vasc Surg. 2026. PMID: 42628689. doi:10.1016/j.avsg.2026.08.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。